Sofosbuvir

ATC J05AP08 · 11 markets · 74 records

Sofosbuvir 11 markets · 74 records Forms

US 15 records · 4 strengths

  • 400 mgtabletEpclusaHarvoni、Sofosbuvir and Velpatasvir、Sovaldi、Vosevi、__no_trade__ also in GB·CN·AU +4
  • 200 mgtabletEpclusaHarvoni、Sovaldi also in GB
  • 200 mgpelletEpclusaHarvoni、Sovaldi
  • 150 mgpelletEpclusaHarvoni、Sovaldi

GB 15 records · 4 strengths

CN 9 records · 1 strengths

  • 400 mgtablet索华迪索磷布韦__mah__:北京凯因格领生物技术有限公司、__mah__:南京正大天晴制药有限公司、__mah__:吉林四环制药有限公司、__mah__:山东世博金都药业有限公司 also in US·GB·AU +4

AU 8 records · 2 strengths

  • 400 mgtabletEpclusaEPCLUSA sofosbuvir 400 mg / velpatasvir 100 mg tablet bottle、HARVONI ledipasvir/sofosbuvir 90 mg/400 mg tablet bottle、Vosevi、VOSEVI sofosbuvir (400 mg), velpatasvir (100 mg), voxilaprevir (100 mg) tablet bottle also in US·GB·CN +4 unknown

Records without a stated strength · 1 Epclusa、Harvoni、Vosevi

ES 8 records · 4 strengths

CA 4 records · 1 strengths

  • 400 mgtabletEpclusaHarvoni、Sovaldi、Vosevi also in US·GB·CN +4

TW 4 records · 2 strengths

  • 400 mgtabletSovaldi索華迪400毫克膜衣錠 also in US·GB·CN +4

Records without a stated strength · 1 Epclusa、Harvoni、Vosevi、夏奉寧膜衣錠、宜譜莎 膜衣錠、沃士維膜衣錠 +3

EU 4 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    Records without a stated strength · 1 Epclusa、Harvoni、Sovaldi、Vosevi +1

    SG 2 records · 1 strengths

    HK 2 records · 1 strengths

      Records without a stated strength · 1 Epclusa、Vosevi

      MX 1 records · 1 strengths

        Records without a stated strength · 1 Vosevi

        Also called: 索非布費、索非布韋 nickname

        The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

        Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

        A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.